North American bronchitis treatment market was valued at $2.2 billion in 2025 and is growing at a CAGR of 5.3% during the forecast period (2026-2035). The North American bronchitis treatment market is a key regional segment within the broader respiratory care landscape, characterized by substantial demand for both acute and chronic bronchitis therapies. The region’s advanced healthcare infrastructure, widespread patient awareness, and high public and private health expenditure underpin its leading share in global bronchitis treatment revenue. In the United States and Canada, robust diagnostic capabilities and a strong presence of pharmaceutical innovators support timely access to established and emerging therapies, making treatment regimens more effective and widely available. The aging population in North America, coupled with persistent environmental factors such as urban air pollution and high smoking prevalence, continues to sustain a significant base of bronchitis and COPD?related cases, thereby driving steady consumption of inhaled medications, bronchodilators, antibiotics, and supportive care solutions.

India product engineering services market was valued at $1.3 billion in 2025 and is growing at a CAGR of 8.4% during the forecast period (2026-2035). The Indian product engineering services market has emerged as a pivotal hub for global innovation, powered by a strong talent pool, cost?efficient delivery models, and deepening domain expertise across sectors such as automotive, healthcare, telecom, and industrial IoT. As enterprises accelerate digital transformation, demand is shifting from traditional support services toward advanced engineering capabilities, including software?defined products, embedded systems, and AI?driven design. Indian engineering service providers are increasingly investing in R&D centers, partnerships, and start?up ecosystems to co?create solutions rather than just execute tasks.

Global aerosol market was valued at $44.1 billion in 2025 and is growing at a CAGR of 5.1% during the forecast period (2026-2035). Fused deposition modeling (FDM), a widely used 3D printing technology, plays an indirect but significant role in the aerosol industry by enabling rapid prototyping and production of custom components such as nozzles, valves, and actuator parts. Its ability to create precise, complex geometries allows manufacturers to test new aerosol packaging designs, optimize fluid dynamics, and improve overall product performance without extensive tooling costs. FDM also supports small-scale production and iterative design modifications, reducing development time and costs. As a result, it contributes to innovation, efficiency, and flexibility in aerosol product development and manufacturing processes.

US medical device technology market was valued at $182.5 billion in 2025 and is growing at a CAGR of 4.7% during the forecast period (2026-2035). The US medical device technology market stands at the intersection of innovation and clinical need, driven by rapid advancements in digital health, minimally invasive procedures, and AI?enabled diagnostic tools. As healthcare systems increasingly prioritize value and outcomes, there’s a growing demand for devices that enhance patient monitoring, streamline workflows, and integrate seamlessly with electronic health records. Regulatory pathways and reimbursement policies continue to evolve, shaping how new technologies are adopted in hospitals, clinics, and outpatient settings. 

Global 3D printing market was valued at $40.6 billion in 2025 and is growing at a CAGR of 20.1% during the forecast period (2026-2035). Aerospace plays a significant role in advancing 3D printing by adopting additive manufacturing to produce complex, high-performance components. The sector utilizes 3D printing to manufacture lightweight structures, engine parts, tooling, and functional prototypes, offering improved design flexibility. Additive manufacturing enables the integration of multiple components into a single part, reducing assembly complexity and material waste. It also supports rapid design iteration, shorter development cycles, and localized production. As aerospace systems increasingly require customized, thermally resistant, and geometrically optimized components, 3D printing continues to support efficiency, performance optimization, and manufacturing resilience across civil, defense, and space applications.

Germany artificial tear market was valued at $230.1 million in 2025 and is projected to reach $379.2 million by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). Market growth is driven by the rising prevalence of dry eye disease (DED) across aging populations, increased screen exposure and digital eye strain, widespread contact lens usage, and growing awareness of ocular surface disorders. Artificial tears play a critical role in managing both aqueous-deficient and evaporative dry eye, with demand spanning preservative-free solutions, lipid-based formulations, and advanced delivery systems. The German market benefits from a strong healthcare infrastructure, high patient compliance, and physician preference for clinically validated, premium ophthalmic formulations. Increasing recommendations from ophthalmologists and optometrists, along with OTC accessibility, continue to support sustained adoption.

US media and entertainment market was valued at $663.5 billion in 2025 and is growing at a CAGR of 8.8% during the forecast period (2026-2035). The US media and entertainment market is undergoing a significant transformation as consumer preferences shift toward digital and on?demand content. One of the most notable changes is the rapid rise of streaming platforms, which for the first time in 2025 accounted for a larger share of television viewing than traditional broadcast and cable combined, reflecting a fundamental shift in how US audiences consume video content.

UK medical device technology market was valued at $19.9 billion in 2025 and is growing at a CAGR of 4.7% during the forecast period (2026-2035). The UK medical device technology market is experiencing steady growth as healthcare providers focus on improving patient outcomes and operational efficiency. Advancements in digital health, minimally invasive procedures, and AI?enabled diagnostics are driving the adoption of innovative medical devices across hospitals, clinics, and outpatient settings. Government initiatives to modernize healthcare infrastructure, streamline regulatory processes, and support domestic manufacturing are creating a favorable environment for both local and international companies.

UK media and entertainment market was valued at $132.0 billion in 2025 and is growing at a CAGR of 7.8% during the forecast period (2026-2035). The UK media and entertainment market is a dynamic and rapidly evolving sector shaped by significant shifts in how people consume content and how revenue is generated. In recent years, traditional broadcast television revenues have declined while online and digital platforms have driven overall industry growth, with commercial TV and online revenues growing even as legacy broadcasters face challenges. Ofcom data shows that overall advertising spend increased, led by online formats rather than traditional TV, reflecting the shift of audience attention to digital channels. At the same time,

China artificial tear market was valued at $335.6 million in 2025 and is projected to reach $588.1 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). Artificial tears are widely used to relieve symptoms of dry eye disease (DED), ocular surface disorders, and digital eye strain, and include formulations such as preservative-free drops, hyaluronic acid-based lubricants, lipid-enhanced emulsions, and gel or ointment variants. Market growth is being driven by the rising prevalence of dry eye associated with aging, increasing screen time and urban digital lifestyles, expanding awareness of ocular health, and improved access to over-the-counter ophthalmic products across hospital pharmacies, retail pharmacies, and e-commerce platforms.